Cargando…

Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive Disorder

BACKGROUND: Incomplete or inadequate response to first-line antidepressant therapy (ADT) for major depressive disorder (MDD) is common. Response to adjunctive therapy is less understood. OBJECTIVE: To estimate response to adjunctive pharmacotherapy or psychotherapy among individuals with MDD on an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forma, Felicia, Liberman, Joshua N, Rui, Pinyao, Wiggins, Emily, Ruetsch, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624149/ https://www.ncbi.nlm.nih.gov/pubmed/36330373 http://dx.doi.org/10.2147/NDT.S369450

Ejemplares similares

Impact of the COVID-19 Pandemic on Healthcare Resource Utilization in Individuals with Major Depressive Disorder
por: Liberman, Joshua N., et al.
Publicado: (2022)

Predicting Poor Outcomes Among Individuals Seeking Care for Major Depressive Disorder
por: Liberman, Joshua N., et al.
Publicado: (2022)

Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder
por: Liberman, Joshua, et al.
Publicado: (2023)

Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United States
por: Liberman, Joshua N., et al.
Publicado: (2022)

Association between Surgical Technical Skills and Clinical Outcomes: A Systematic Literature Review and Meta-Analysis
por: Woods, Michael S., et al.
Publicado: (2023)

Mental Health Care Provider's Perspectives Toward Adopting a Novel Technology to Improve Medication Adherence
por: Liberman, Joshua N., et al.
Publicado: (2022)

The Association between Patient Activation and Outcomes among Severely Mentally Ill Patients
por: Forma, Felicia, et al.
Publicado: (2020)

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms
por: Ruetsch, Charles, et al.
Publicado: (2021)

Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
por: Vieta, Eduard, et al.
Publicado: (2019)

Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care
por: Liberman, Joshua N., et al.
Publicado: (2020)

Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder
por: Yan, Tingjian, et al.
Publicado: (2020)

Adjunctive Bright Light Therapy for Non-Seasonal Major Depressive Disorder: A Randomized Controlled Trial
por: Chen, I-Peng, et al.
Publicado: (2022)

Efficacy of physical activity in the adjunctive treatment of major depressive disorders: preliminary results
por: Pilu, Alessandra, et al.
Publicado: (2007)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori L., et al.
Publicado: (2016)

Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial
por: Guimarães, Mara C., et al.
Publicado: (2021)

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
por: Bruijnzeel, Dawn, et al.
Publicado: (2016)

Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder
por: Cao, Bo, et al.
Publicado: (2018)

Improving physical quality of life with group physical activity in the adjunctive treatment of major depressive disorder
por: Carta, Mauro Giovanni, et al.
Publicado: (2008)

Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy
por: Nelson, J. Craig, et al.
Publicado: (2014)

A Case Series: Adjunctive Treatment of Major Depressive Disorder in the Geriatric Population with the Methylphenidate Patch
por: Patel, Kamal, et al.
Publicado: (2019)

Intranasal Oxytocin as an adjunct treatment in patients with major depression with and without comorbid borderline personality disorder
por: Maoz, H.
Publicado: (2023)

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
por: Hobart, Mary, et al.
Publicado: (2019)

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
por: Spielmans, Glen I., et al.
Publicado: (2013)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
por: De Berardis, Domenico, et al.
Publicado: (2020)

Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers
por: Shafrin, Jason, et al.
Publicado: (2017)

Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
por: Hardoy, Maria Carolina, et al.
Publicado: (2010)

Author Correction: Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder
por: Cao, Bo, et al.
Publicado: (2020)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
por: Martinez, James M, et al.
Publicado: (2015)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
por: Weiller, Emmanuelle, et al.
Publicado: (2017)

PS151. Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study
por: Davis, Lori, et al.
Publicado: (2016)

Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study
por: Lepola, Ulla, et al.
Publicado: (2018)

Adjunctive transcranial alternating current stimulation for patients with major depressive disorder: A systematic review and meta-analysis
por: Zheng, Wei, et al.
Publicado: (2023)

Adjunctive repetitive transcranial magnetic stimulation for adolescents with first-episode major depressive disorder: a meta-analysis
por: Sun, Chen-Hui, et al.
Publicado: (2023)

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
por: Walker, Adam J., et al.
Publicado: (2022)

Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study
por: Amr, Mostafa, et al.
Publicado: (2013)

Linguistic analysis of the autobiographical memories of individuals with major depressive disorder
por: Himmelstein, Philip, et al.
Publicado: (2018)

Individual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms
por: Misaki, Masaya, et al.
Publicado: (2016)

Ketamine as an adjunctive therapy for major depression - a randomised controlled pragmatic pilot trial (Karma-Dep Trial)
por: Gallagher, Bronagh, et al.
Publicado: (2022)

Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
por: McIntyre, Roger S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i5350389osu6eue8to1acbk5qb